Cytokinetics Inc. buy Truist Financial Co.
Start price
08.04.24
/
50%
€68.00
Target price
08.04.25
€79.21
Performance (%)
-13.97%
Price
29.04.24
€58.50
Summary
This prediction is currently active. The prediction for Cytokinetics Inc. disappoints with a performance of -13.97%. This prediction currently runs until 08.04.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Cytokinetics Inc. | -6.400% |
iShares Core DAX® | 0.961% |
iShares Nasdaq 100 | 2.626% |
iShares Nikkei 225® | 0.217% |
iShares S&P 500 | 1.540% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $86.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€76.00
28.12.23
28.12.23
€77.64
28.12.24
28.12.24
-23.03%
29.04.24
29.04.24